Compounds with Medicinal Value
In industrialized countries over the last few decades, there has been a significant increase in infectious; cardiovascular, inflammatory, and neurodegenerative diseases; as well as different forms of cancer, diabetes, and so on.
Between them, microbial infections and cancer are still the major causes of death among the world’s population due to increased bacterial resistance phenomena and the development of resistance to chemotherapeutics. For these reasons, there is an urgent need to design and synthesize new antimicrobial agents, particularly those with antibacterial activity, and particularly against Gram-negative pathogens that could be used to fight drug resistance, and also for new antineoplastic drugs with higher selectivity on tumoral cells, which are able to overcome cancer cells’ resistance with minimal side effects.
Recently, some delivery systems have proved particulary effective as antimicrobial and anticancer carriers due to targeted drug delivery at the action sites, reduced drug-resistance and side effects, and an increased therapeutic index.
Potential topics for manuscripts include the following:
The design, synthesis, and biological evaluation of anticancer agents;
The design, synthesis, and biological evaluation of antimicrobial agents;
Delivery systems and nanosystems for targeted cancer and antimicrobial therapy...
Deadline for abstract submissions: 31 December 2021.
Deadline for manuscript submissions: 31 March 2022.
Interests: the study of new molecules as anticancer drugs; the design, synthesis and biological evaluation of compounds of pharmaceutic interest; the study and biological evaluation of nutraceuticals
Special Issues and Collections in MDPI journals
Special Issue in Applied Sciences: The Design, Synthesis, and Biological Evaluation of Compounds with Medicinal Value
Special Issue in Applied Sciences: Synthesis and Application of Heterocyclic Compounds
Special Issue in Applied Sciences: Heavy Metal Toxicity: Environmental and Human Health Risk Assessment
Special Issue in Antibiotics: What’s New: Natural and Synthetic Antibacterials and/or Agents with Multiple Activities?
|Journal Name||Impact Factor||CiteScore||Launched Year||First Decision (median)||APC|
|2.679||3.0||2011||13.8 Days||2000 CHF||Submit|
|4.879||3.2||2011||16.29 Days||2000 CHF||Submit|
|5.863||4.6||2004||13.7 Days||1800 CHF||Submit|
|6.081||3.6||2013||16.34 Days||2000 CHF||Submit|
|4.639||2.8||2012||13.26 Days||1800 CHF||Submit|